hnRNP UL2 Inhibitors
HnRNP UL2 inhibitors encompass a range of chemical compounds that interfere with various signaling pathways and kinases involved in the post-transcriptional regulation of gene expression. These inhibitors affect hnRNP UL2 by altering the phosphorylation state of the protein, which is critical for its functional activity. For instance, PI3K inhibitors like LY294002 can lead to the inactivation of Akt, which may prevent the phosphorylation of hnRNP UL2, should it be an Akt substrate. Similarly, MEK inhibitors such as PD98059 and U0126 restrict the ERK pathway, which could decrease the phosphorylation and subsequent activity of hnRNP UL2 if it is regulated by this pathway. MAPK pathway inhibitors like SB203580 and SP600125 act on p38 and JNK, respectively, potentially reducing hnRNP UL2 activity by preventing its phosphorylation by these kinases.
Other inhibitors, such as BAPTA-AM and W-7 Hydrochloride, target calcium-dependent signaling mechanisms. The former chelates calcium ions, while the latter antagonizes calmodulin, which in turn could inhibit calmodulin-dependent kinases that may control hnRNP UL2 activity. The reduction of intracellular calcium levels or calmodulin inhibition may lead to less hnRNP UL2 phosphorylation by these kinases. PKC inhibitors like Ro 31-8220 could suppress hnRNP UL2 activity by inhibiting phosphorylation events mediated by PKC, assuming hnRNP UL2 is a substrate of PKC. Furthermore, the inhibition of mTOR signaling by rapamycin might lead to a decrease in hnRNP UL2 function, especially if hnRNP UL2 synthesis or activity is mTORC1-dependent. KN-93's inhibition of CaMKII could similarly result in decreased hnRNP UL2 activity if it is a CaMKII substrate.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
A specific inhibitor of PI3K, LY294002, can lead to the inhibition of the Akt pathway. When Akt is inactivated, there is a subsequent decrease in the phosphorylation of downstream targets, which may include proteins like hnRNP UL2 that depend on phosphorylation for their activity. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
A MEK inhibitor that, by blocking MEK1/2, leads to the inhibition of the ERK pathway. Reduced activity of ERK can result in decreased phosphorylation of proteins involved in RNA processing, potentially including hnRNP UL2, thus inhibiting its function. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
An inhibitor of p38 MAPK, SB203580 can diminish the activation of MAPK-dependent proteins. This inhibition can alter the phosphorylation state and function of hnRNP UL2 if it is a substrate of p38 MAPK-related kinases. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
An inhibitor of JNK, SP600125, can reduce the activity of JNK and its downstream targets. If hnRNP UL2 function is modulated by JNK-mediated phosphorylation, this compound could inhibit hnRNP UL2 activity. | ||||||
BAPTA/AM | 126150-97-8 | sc-202488 sc-202488A | 25 mg 100 mg | $138.00 $458.00 | 61 | |
A calcium chelator that can reduce intracellular calcium levels, BAPTA-AM can affect calcium-dependent protein kinases. If hnRNP UL2 is regulated by such kinases, its activity would be inhibited by decreased calcium signaling. | ||||||
W-7 | 61714-27-0 | sc-201501 sc-201501A sc-201501B | 50 mg 100 mg 1 g | $166.00 $306.00 $1675.00 | 18 | |
A calmodulin antagonist, W-7 Hydrochloride can inhibit calmodulin-dependent protein kinases. If hnRNP UL2 requires calmodulin for its function, this inhibition would result in decreased hnRNP UL2 activity. | ||||||
Ro 31-8220 | 138489-18-6 | sc-200619 sc-200619A | 1 mg 5 mg | $92.00 $245.00 | 17 | |
A potent PKC inhibitor, Ro 31-8220 could inhibit the phosphorylation of proteins controlled by PKC. If hnRNP UL2 is a PKC substrate, this inhibition would lead to a decrease in hnRNP UL2 activity. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
An mTOR inhibitor, rapamycin can suppress mTORC1-dependent signaling. This suppression can lead to reduced protein synthesis of some RNA-binding proteins and might inhibit hnRNP UL2 function if it is mTORC1-sensitive. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
An inhibitor of MEK1/2, U0126 prevents the activation of ERK1/2. If hnRNP UL2 is regulated by the ERK pathway, inhibition by U0126 could reduce hnRNP UL2 activity. | ||||||
KN-93 | 139298-40-1 | sc-202199 | 1 mg | $182.00 | 25 | |
An inhibitor of CaMKII, KN-93 can prevent calcium/calmodulin-dependent protein kinase II activation. Reduced CaMKII activity could lead to inhibition of hnRNP UL2 if it is a CaMKII substrate. | ||||||